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Between 1986 and July 1990, balloon valvuloplasty was attempted 
in eight newborns «28 days of age) with isolated critical aortic 
valve stenosis. Balloon valvuloplasty could not be successfully 
accomplished in any of the three infants presenting before 1989. 
Since March 1989, when improved catheter technology became 
available, all five neonates presenting with critical aortic stenosis 
were treated successfully by balloon valvuloplasty. A transumbil-
ical approach was utilized in all four infants in whom umbilical 
artery access could be obtained. One newborn who was 25 days of 
age underwent transfemoral balloon valvuloplasty. 
Balloon valvuloplasty was immediately successful in all five 
newborns, as evidenced by a decrease in valve gradient and 
improvement in left ventricular function and cardiac output. Peak 
systolic gradient was reduced by 64% from 69 ± 8 to 25 ± 3 mm 
Hg (p = 0.005). Left ventricular systolic pressure decreased from 
Balloon valvuloplasty has been shown to provide effective 
gradient relief in children with congenital aortic valve steno-
sis (1-4), with minimal intermediate-term restenosis (5). 
There has been limited experience, however, with balloon 
valvuloplasty in the treatment of newborns with critical 
aortic stenosis. Femoral artery access may be difficult to 
obtain percutaneously in sick neonates with diminished 
pUlses. Furthermore, we and others (5-7) have been con-
cerned about the risk of femoral artery injury when percu-
taneous valvuloplasty procedures are performed transarteri-
ally during the newborn period. Nevertheless, because 
surgical treatment of critical aortic stenosis in the newborn is 
associated with significant morbidity and mortality (8-12), 
transcatheter therapy may have an important therapeutic 
role in this group of patients. 
The purpose of this report is to describe the experience at 
our institution with balloon valvuloplasty in neonates with 
critical aortic stenosis. The impact of recent improvements 
in catheter technology on the successful application of 
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128 ± 9 to 95 ± 9 mm Hg (p = 0.02) and left ventricular 
end-diastolic pressure decreased from 20 ± 2 to 11 ± 1 mm Hg 
(p = 0.02). Moderate (2+) aortic regurgitation was documented in 
two infants after valvuloplasty. The time from first catheter 
insertion to valve dilation averaged 57 ± 14 min (range 26 to 94) 
and the median length of the hospital stay was 4 days. 
With the use of recently available catheters, the transumbilical 
technique of balloon valvuloplasty can be performed quickly, 
safely and effectively in the newborn with critical aortic stenosis. 
It does not require general anesthesia, cardiopulmonary bypass or 
a left ventricular apical incision and it preserves the femoral 
arteries for future transcatheter intervention should significant 
aortic stenosis recur. 
(J Am Coll CardioI1991;17:1172-6) 
transcatheter therapy in newborn aortic stenosis is docu-
mented. Since 1989, when improved angioplasty catheters 
became available at our institution, all neonates presenting 
with critical aortic stenosis have undergone successful bal-
loon valvuloplasty. Furthermore, the transumbilical ap-
proach has been utilized in all infants <2 weeks of age, thus 
avoiding potential femoral artery injury. 
Methods 
Study patients. Between 1986 and July 1990, balloon 
valvuloplasty was attempted in eight newborns «28 days of 
age) with isolated critical aortic valve stenosis. The patients 
ranged in age from 2 to 27 days and in weight from 3.3 to 
4.2 kg. All had congestive heart failure and markedly dimin-
ished peripheral arterial pulses. Balloon valvuloplasty was 
offered as an investigational treatment alternative to surgical 
valvotomy and consent was obtained from each patient's 
family. The valvuloplasty protocol was approved by the 
Institutional Review Board at the University of Michigan 
Medical Center (May 14, 1985). We did not attempt balloon 
valvuloplasty in newborns with aortic stenosis and associ-
ated severe left ventricular hypoplasia «20 ml/m2 end-
diastolic volume). 
Balloon valvuloplasty could not be successfully accom-
plished in any of the three infants presenting before 1989. 
Since March 1989, however, when improved catheter tech-
nology became available at our institution, all five neonates 
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presenting with critical aortic stenosis were treated success-
fully by balloon valvuloplasty. 
Valvuloplasty attempts before 1989. All three valvulo-
plasty attempts before March 1989 were unsuccessful be-
cause of technical difficulties related to the balloon catheters 
available at the time. The first patient was a 5 day old infant 
(3.3 kg) with critical aortic stenosis. Transfemoral balloon 
valvuloplasty was attempted with use of a 6 mm balloon 
catheter (7F, Meditech). The catheter was introduced into 
the left femoral artery but could not be advanced beyond the 
iliac artery. With considerable difficulty, the catheter was 
removed and a cuff of intimal tissue was withdrawn along 
with the catheter. Hemostasis was easily obtained, but the 
left femoral pulse was lost. The child subsequently under-
went surgical aortic valvotomy and has done well during a 3 
year follow-up period. The left femoral pulse remains ab-
sent, but without apparent clinical sequelae. 
The second patient was a 2 day old infant (3.4 kg) with 
critical aortic stenosis who presented with severe congestive 
failure and diminished peripheral pulses. The femoral arter-
ies could not be entered percutaneously and an attempted 
trans umbilical valvuloplasty procedure was unsuccessful. 
Through an umbilical artery, a 5 mm coronary angioplasty 
catheter (4.3F, Schwarten) was introduced over a 0.016 in. 
(0.04 cm) coronary exchange wire. It was extremely difficult 
to advance the catheter through the umbilical-iliac artery 
system and 60 min of catheter and wire manipulation were 
required before the balloon was positioned in the ascending 
aorta. Before the balloon was positioned across the aortic 
valve, a single inflation was performed and the balloon burst. 
The procedure was therefore abandoned and the infant 
prepared for emergency surgical valvotomy. He died in the 
operating room. 
The third patient was a 4 day old infant (3.8 kg) with 
critical aortic stenosis. Because of extremely poor pulses, 
only one femoral artery could be entered percutaneously. A 
5 mm coronary balloon catheter (4.3F, Schwarten) was 
utilized to dilate the aortic valve. Although the balloon was 
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Figure 1. Proflex 5 catheter with balloon deflated. The low profile of 
the un inflated balloon facilitates introduction and manipulation of 
the catheter through the newborn umbilical artery system. 
recognized to be undersized for the valve anulus diameter 
(8 mm), on the basis of our earlier experience, it was 
believed that a larger catheter would pose excessive risks to 
the femoral artery. The valvuloplasty procedure reduced the 
peak systolic gradient transiently from 70 to 40 mm Hg, but 
severe stenosis recurred within several days and surgical 
valvotomy was required. The infant has done well, with a 
present but diminished right femoral pulse. 
Valvuloplasty procedures since March 1989. In March 
1989, new balloon catheter technology became available at 
our institution. The catheter consists of a 5.3F shaft on 
which a 6,7 or 8 mm diameter balloon is mounted (Proflex 5, 
Peripheral Systems Group, Advanced Cardiovascular Sys-
tems). The uninftated balloon has a very low profile (Fig. 1) 
and the catheter itself is coated with a silicone-based mate-
rial that enables it to easily traverse the umbilical-iliac artery 
system over a 0.035 in. (0.089 cm) guide wire. Utilizing this 
catheter, all five newborns with critical aortic stenosis who 
presented between March 1989 and July 1990 underwent 
successful transcatheter therapy (Table 1). Furthermore, all 
four infants in whom umbilical artery access could be 
obtained underwent valve dilation using the transumbilical 
approach. One newborn who was 25 days of age underwent 
transfemoral balloon valvuloplasty. 
Valvuloplasty technique. The transumbilical technique of 
balloon aortic valvuloplasty has been remarkably simple. If 
Table 1. Pertinent Clinical and Hemodynamic Data From Five Newborns With Critical Aortic Stenosis Undergoing Successful Balloon 
Valvuloplasty (March 1989 to July 1990) 
Anulus Balloon 
Grad LVS LVED AR 
(mmHg) (mmHg) (mmHg) (0 to 4+) LVSF(%) Hospital Case Age Wt Diameter Diameter Fluoro Stay 
No. (days) (kg) (mm) (mm) Approach (min) Pre Post Pre Post Pre Post Pre Post Pre Post (days) 
1 2 3.3 6.5 7 Umbilical 38 70 15 120 72 28 12 0 2 * 30 16 
2 6 3.9 6.5 7 Umbilical 21 60 30 110 104 14 12 0 0 * 35 4 
3 9 4.1 8 7 Umbilical 24 74 32 142 120 20 10 0 0 22 38 3 
4 11 4.2 7 7 Umbilical IS 96 29 155 104 17 9 0 0 18 34 4 
5 25 4.2 8 7 Femoral 21 45 20 115 75 20 14 0 2 20 35 4 
Mean 10.6 3.9 7.2 23.8 69 25.2 128 95 19.8 11.4 20 34 6.2 
± SE 3.9 0.2 0.3 3.8 8.4 3.3 8.6 9.3 2.3 0.9 01 2.5 
P value 0.005 0.02 0.02 0.005 
·Measurement not obtainable because of paradoxic septal motion. AR = aortic regurgitation; Fluoro = total duration of fluoroscopy; Grad = peak systolic 
gradient; LVED = left ventricular end-diastolic pressure; LVS = left ventricular systolic pressure; LVSF = left ventricular shortening fraction (by 
echocardiography); Post = after valvuloplasty; Pre = before valvuloplasty; Wt = weight. 
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PRE·VALVULOPLASTY POST·VALVULOPLASTY 
possible, we prefer to introduce a 5F umbilical catheter into 
each umbilical artery and a 4 or 5F transvenous catheter into 
the left ventricle through the foramen ovale. Thus, both left 
ventricular and aortic pressures can be monitored through-
out the procedure (Fig. 2). Over a 0.021 in. exchange wire, a 
4F pigtail catheter (Universal Medical Instruments) is ex-
changed for one umbilical artery catheter. In a retrograde 
fashion, the pigtail catheter is advanced across the aortic 
valve to the left ventricular apex. The 4F pigtail catheter is 
then removed and a 5F pigtail catheter (Universal Medical 
Instruments) is advanced over the exchange wire into the left 
ventricle. The 5F catheter is utilized to introduce a 0.035 in. 
curved-tipped exchange wire into the left ventricle. The 
pigtail catheter is removed and the valvuloplasty catheter 
advanced over the exchange wire. The Proflex 5 catheter 
tracks a 0.035 in. exchange wire very well and easily 
traverses the umbilical-iliac artery system. The balloon size 
is chosen to approximately equal the valve anulus diameter 
as estimated by echocardiography (angiography is mini-
mized before valvuloplasty); in all five cases, a 7 mm 
diameter balloon catheter was utilized. 
The balloon is positioned across the aortic valve and 
inflated by hand, with a mixture of contrast medium and 
saline solution, until the waist created on the balloon by the 
valve disappears. Balloon inflation is limited to a 5 to 10 s 
period, after which the catheter is withdrawn to the descend-
ing aorta. Left ventricular and aortic pressures are measured 
to document the acute hemodynamic effects of valvuloplasty 
(the second umbilical artery and transvenous left ventricular 
catheters facilitate this measurement without the need to 
first remove the valvuloplasty catheter) (Fig. 2). The valvu-
loplasty catheter is then removed and a pigtail catheter 
advanced to the ascending aorta, where an aortogram is 
filmed to evaluate the degree of valve regurgitation that may 
be present after the procedure. Hemostasis was obtained 
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Figure 2. Case 4. Aortic and left ventricular 
pressures before and after transumbilical valvu-
loplasty in an 11 day old neonate with critical 
aortic stenosis. A catheter was inserted into each 
umbilical artery (note two aortic tracings before 
valvuloplasty) to permit accurate hemodynamic 
monitoring during and after valve dilation with-
out the need to exchange the valvuloplasty cath-
eter. In this infant, valvuloplasty immediately 
reduced the peak aortic valve gradient from 
96 mm Hg to 29 mm Hg and the left ventric-
ular end-diastolic pressure from 17 mm Hg to 
9 mm Hg. 
easily in all patients by using only digital pressure on the 
umbilical artery. After an episode of staphylococcal sepsis in 
one child, we now provide antibiotic coverage during trans-
umbilical valvuloplasty procedures. 
Results 
Clinical and hemodynamic features. Table 1 presents per-
tinent clinical and hemodynamic data for all five neonates 
with critical aortic stenosis who underwent balloon valvulo-
plasty between March 1989 and July 1990. This group 
represents all newborns with isolated critical aortic stenosis 
presenting to our institution during this period. The infants 
ranged in age from 2 to 25 days and in weight from 3.3 to 
4.2 kg. All had severe congestive heart failure. Two-
dimensional echocardiograms demonstrated markedly di-
minished left ventricular systolic function in all five infants, 
with a left ventricular shortening fraction ranging from 18% 
to 22% (shortening fraction could not be measured in two 
children because of paradoxic septal motion). The aortic 
valve anulus ranged from 6.5 to 8 mm in diameter. In all five 
infants the 12 lead electrocardiogram (EeG) showed left 
ventricular hypertrophy with ischemic ST-T wave changes. 
The 2 day old infant was intubated and received dopamine 
and prostaglandin E\ infusions during the procedure. 
Hemodynamic response (Table 1). Balloon valvuloplasty 
was acutely successful in each newborn, as evidenced by a 
decrease in valve gradient accompanied by an immediate 
improvement in left ventricular function and cardiac output. 
Peak systolic aortic valve gradient was reduced by 64% from 
69 ± 8 to 25 ± 3 mm Hg (p = 0.005). Left ventricular systolic 
pressure decreased from 128 ± 9 to 95 ± 9 mm Hg (p = 0.02) 
and left ventricular end-diastolic pressure decreased from 
20 ± 2 to 11 ± 1 mm Hg (p = 0.02). Because of the urgent 
nature of the valvuloplasty procedure in these infants, car-
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diac output was not routinely measured. Mixed venous 
oxygen saturation was measured in three infants and in-
creased by > 10% immediately after valvuloplasty in each 
case (from 53 ± 4% to 70 ± 6%, p = 0.10). Moderate (2+) 
aortic regurgitation was documented in two infants after 
valvuloplasty. The time from first catheter insertion to valve 
dilation averaged 57 ± 14 min (range 26 to 94) and the 
duration of fluoroscopy (anteroposterior and lateral planes) 
for the five procedures averaged 24 ± 4 min (range 15 to 38). 
Clinical response (Table 1). In parallel with the hemody-
namic changes, almost immediate clinical improvement was 
noted in each infant. After valvuloplasty, the peripheral 
arterial pulses normalized promptly and the signs and symp-
toms of congestive failure resolved. Within 1 to 2 days after 
valvuloplasty, left ventricular shortening fraction returned to 
normal in all five infants. The ischemic ST-T changes on the 
ECG resolved in two infants and improved in one infant. The 
median length of the hospital stay was 4 days. One infant 
(Case 1) remained hospitalized for 16 days primarily because 
of complications related to a subclavian venous line. A 
second infant (Case 3) became febrile 4 days after hospital 
discharge and a blood culture grew Staphylococcus epider-
midis. He was readmitted and successfully treated for sep-
sis; there was no evidence of omphalitis or endocarditis. 
The five infants have been followed up for 2 to 16 months 
after valvuloplasty. All are doing well without recurrence of 
severe stenosis and none has required repeat valvuloplasty 
or surgical intervention during this brief follow-up period. 
All four infants who underwent trans umbilical valvuloplasty 
have normal femoral artery pulses and the 25 day old infant 
who required a transfemoral procedure has a diminished but 
palpable femoral pUlse. 
Discussion 
Critical aortic stenosis of the newborn must be treated 
promptly and effectively. Surgical therapy, either open val-
votomy or closed valve dilation, has been associated with 
significant morbidity and mortality (8-12). Surgical treat-
ment requires general anesthesia, cardiopulmonary bypass 
and, in the case of closed valve dilation, an incision in the 
left ventricular apex. Transcatheter therapy, therefore, may 
offer significant advantages over surgical treatment in this 
group of patients. In the current report, we have docu-
mented that balloon valvuloplasty can be performed quickly 
and effectively utilizing newly available balloon catheters. 
Since March 1989, valvuloplasty was applied successfully in 
all five neonates presenting to our institution with critical 
aortic valve stenosis. Balloon aortic valvuloplasty reduced 
the peak systolic gradient from an average of 69 ± 8 mm Hg 
to 25 ± 3 mm Hg, with an associated improvement in left 
ventricular function and cardiac output. Severe aortic regur-
gitation was not created and congestive heart failure re-
solved in all children. The infants were discharged after a 
median hospital stay of 4 days' duration. 
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Previous reports. Balloon valvuloplasty in neonates with 
critical aortic valve stenosis has been reported previously. 
Kasten-Sportes et al. (13) attempted transfemoral balloon 
valvuloplasty in 10 newborns with critical aortic stenosis and 
reported effective gradient reduction in all 7 infants who had 
a technically satisfactory procedure. In one infant, the aortic 
valve was perforated by an exchange wire and subsequently 
dilated, causing severe aortic regurgitation and death. Sim-
ilarly, Zeevi et al. (14) reported balloon valvuloplasty in 16 
neonates with critical aortic stenosis. The procedure was 
performed by means of the transumbilical approach in six, 
but technical aspects of the trans umbilical dilation were not 
described. A satisfactory outcome was obtained in all neo-
nates without a hypoplastic left ventricle. Follow-up hemo-
dynamic evaluation 17.6 months after valvuloplasty in nine 
infants documented an average residual gradient of approx-
imately 45 mm Hg, without moderate to severe aortic 
regurgitation in any infant. 
Risk offemoral artery injury. Because available valvulo-
plasty catheters have been large in relation to femoral artery 
size, transfemoral angioplasty procedures have been associ-
ated with a substantial incidence of femoral artery compli-
cations when performed in infancy (5-7,15). Burrows et al. 
(6) reported ileofemoral artery thrombosis, aneurysm, dis-
ruption or tearing with prolonged bleeding in 28 of 72 infants 
and young children after transfemoral balloon angioplasty 
procedures. Similarly, Saul et al. (15) described femoral 
artery occlusion in 9 of 13 infants <2 years of age after 
transfemoral balloon dilation of postoperative aortic ob-
struction. Several strategies have been reported in an at-
tempt to decrease the risk of femoral artery injury after 
balloon angioplasty of left-sided obstructive lesions in in-
fancy. These have included double balloon dilation to allow 
insertion of smaller valvuloplasty catheters (3,16), trans-
venous angioplasty by means of the trans septal route (17) 
and intraoperative angioplasty through a thoracotomy (18). 
Fischer et al. (19) recently reported performing balloon 
valvuloplasty of newborn aortic stenosis through a right 
common carotid artery cutdown. The rationale for all of 
these approaches has been to avoid potential femoral artery 
injury that may occur with transfemoral arterial angioplasty 
in infancy. 
The transumbilical approach with improved catheters. In 
the current report, we documented that balloon valvulo-
plasty can be performed quickly and effectively in the 
newborn with critical aortic stenosis by using a transumbil-
ical approach that does not require catheterization of the 
femoral artery. At our institution, successful application of 
the trans umbilical technique has been the direct conse-
quence of recent improvements in catheter technology. 
Balloons 6 to 8 mm in diameter are now available on a 5.3F 
catheter (Proflex 5) that tracks the umbilical artery course 
with ease. Since obtaining the Proflex 5 catheter, we per-
formed valvuloplasty successfully in all five neonates with 
critical aortic stenosis who presented to our institution. The 
transumbilical approach was utilized in the four newborns 
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<2 weeks of age and all have normal femoral pUlses. The 
fifth child was 25 days old and had no umbilical access. He 
therefore underwent transfemoral valve dilation utilizing the 
same 5.3F catheter and subsequently has a mildly dimin-
ished femoral pulse. 
Conclusions. Balloon valvuloplasty appears to be an 
effective treatment alternative to surgery in newborns with 
critical aortic stenosis. Furthermore, utilizing new catheter 
technology, the transumbilical approach can be successfully 
employed, thus providing an easily accessible route for 
aortic valvuloplasty that does not require femoral artery 
catheterization. Although data based on five patients must 
be considered preliminary, we have adopted transumbilical 
balloon valvuloplasty as our preferred treatment for the 
newborn with critical aortic stenosis. It does not require 
general anesthesia, cardiopulmonary bypass or a left ven-
tricular apical incision (utilized with closed surgical valvot-
omy) and preserves the femoral arteries for future transcath-
eter intervention should significant aortic stenosis recur. If 
umbilical access is unavailable, surgical valvotomy remains 
a satisfactory option because of the risk of femoral artery 
injury when transfemoral aortic balloon valvuloplasty is 
performed in early infancy. 
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